TICH-2 TRIAL - TRANEXAMIC ACID FOR INTRACEREBRAL HAEMORRHAGE 2

被引：0

作者：

Sprigg, N. ^{[1
]}

Bath, P. ^{[1
]}

Appleton, J. ^{[1
]}

Foster, H. ^{[1
]}

Adrian, M. ^{[1
]}

Stringer, M. ^{[1
]}

Longmate, J. ^{[1
]}

Keeling, J. ^{[1
]}

Kirby, J. ^{[1
]}

Smithson, J. ^{[1
]}

Robson, K. ^{[1
]}

Scutt, P. ^{[1
]}

机构：

[1] Univ Nottingham, Stroke Div Clin Neurosci, Nottingham, England

来源：

INTERNATIONAL JOURNAL OF STROKE | 2016年 / 11卷 / SUPP 3期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

597

引用

页码：233 / 233

页数：1

共 50 条

[41] Obtaining Consent in Emergency Clinical Tlrials: Data from the on-going Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH 2)
Sprigg, N.
Robson, K.
Krishnan, K.
Bath, P. M.
CEREBROVASCULAR DISEASES, 2014, 37 : 417 - 417
[42] Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: A statistical analysis plan of a pre-specified sub-study of the TICH-2 trial ISRCTN93732214 ISRCTN
Ovesen C.
Jakobsen J.C.
Gluud C.
Steiner T.
Law Z.
Flaherty K.
Dineen R.A.
Bath P.M.
Sprigg N.
Christensen H.
BMC Research Notes, 11 (1)
[43] RADIOLOGICAL MARKERS ON NON-CONTRAST CT FOR PREDICTING OUTCOME AFTER INTRACEREBRAL HAEMORRHAGE: A RETROSPECTIVE ANALYSIS FROM RANDOMIZED CONTROLLED TRIAL TICH-2 DATA
Bischoff, A.
Law, Z.
Krishnan, K.
Ali, A.
Flaherty, K.
Appleton, J.
Bath, P. M.
Sprigg, N.
AGE AND AGEING, 2018, 47
[44] Obtaining consent in emergency clinical trials: Data from the on-going Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH 2) study
Sprigg, N.
Robson, K.
Krishnan, K.
Bath, P.
INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 38 - 38
[45] TRANEXAMIC ACID FOR INTRACEREBRAL HAEMORRHAGE 3 (TICH-3): RATIONALE AND DESIGN OF A PHASE III DOUBLE BLIND RANDOMISED CONTROLLED MULTICENTRED SUPERIORITY TRIAL
Mhlanga, I.
Sprigg, N.
Woodhouse, L.
Dineen, R.
Werring, D.
Coats, T.
Salman, R.
Roffe, C.
England, T.
Montgomery, A.
Roberts, I.
James, M.
Bath, P. M.
Rick, C.
Robinson, T.
Hepburn, T.
Desborough, M.
INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 166 - 166
[46] Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial (vol 8, e019930, 2018)
Dineen, R. A.
Pszczolkowski, S.
Flaherty, K.
BMJ OPEN, 2018, 8 (04):
[47] Endogenous plasminogen activators association with haematoma expansion and neurological deterioration in spontaneous intracerebral haemorrhage: findings from the TICH-2 plasma biomarkers sub-study
Law, Z. K.
Rakkar, K.
Scutt, P.
Appleton, J. P.
Bath, P. M.
Bayraktutan, U.
Sprigg, N.
INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 49 - 49
[48] Tranexamic Acid For Intracerebral Haemorrhage 3 (Tich-3): Rationale And Design Of A Phase Iii Double Blind Randomised Controlled Multi-Centred Superiority Trial
Sprigg, N.
Menon, C.
Desborough, M.
Hepburn, T.
Roberts, I.
Montgomery, A.
Salman, R. Al-Shahi
Roffe, C.
Werring, D.
Coats, T.
Rick, C.
Robinson, T.
England, T.
Mhlanga, I.
Bath, P.
INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (3_SUPPL) : 69 - 69
[49] Baseline characteristics of patients enrolled in the start up phase of tranexamic acid for hyperacute primary intracerebral hemorrhage (TICH 2)
Sprigg, N.
Robson, K.
Krishnan, K.
Bath, P. M. W.
INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 212 - 212
[50] TRANEXAMIC ACID FOR INTRACEREBRAL HAEMORRHAGE 3 (TICH-3): RATIONALE AND DESIGN OF A PHASE III DOUBLE BLIND RANDOMISED CONTROLLED MULTI-CENTRED SUPERIORITY TRIAL
Sprigg, N.
Mhlanga, I.
Menon, C.
Desborough, M.
Hamilton, T.
Dineen, R.
Dutton, B.
Dib, J.
Hepburn, T.
Montgomery, A.
Roberts, I.
Salman, R.
Roffe, C.
Werring, D.
Coats, T.
James, M.
England, T.
Woodhouse, L.
Bath, P.
INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 330 - 330

← 1 2 3 4 5 →